XML 82 R65.htm IDEA: XBRL DOCUMENT v3.24.1
Schedule of Restricted Stock Award Activity (Details) (Paranthetical) - Restricted Stock [Member] - shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
[1]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Number of restricted stock awards, unvested 2,337,440 2,091,420 1,940,740
Number of restricted stock awards, vested 303,980 169,320  
Outside of 2018 Plan [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Number of restricted stock awards, unvested   50,000  
Number of restricted stock awards, vested 50,000    
[1] The unvested restricted stock awards presented in the table above, are inclusive of 50,000 restricted stock awards granted outside the Lucid Diagnostics 2018 Equity Plan as of December 31, 2022. These 50,000 restricted stock awards were fully vested during the year ended December 31, 2023.